Acetadote (Acetylcysteine) Patent Expiration, LOE Window & CMS Spending

Acetadote (Acetylcysteine) by Apotex: FDA Orange Book LOE 2032-04-06, 0 AB generics, $22K 2024 CMS Part D & Medicaid spend.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorApotex
FDA Application & PathwayN021539 (NDA)
Exclusivity / Cliff HorizonMid-Term Protection (2031-2035)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity Date2032-04-06
Orange Book Patents (*PED Extensions)3 patents (0 *PED)
Active AB-Rated Generic Competitors0
2024 CMS Total Public Spend$22K
2024 Medicare Part D Spend$0
2024 Medicaid Spend$22K
Reported Wholesale Price Change (CA SB 17)0 statutory filings in 2023 to 2026 panel